Apolipoprotein AI amyloid deposits in the ligamentum flavum in patients with lumbar spinal canal stenosis

References

• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583–596.
   PubMed Web of Science ®Google Scholar
• Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med. 2004;255(2):159–178.
   PubMed Web of Science ®Google Scholar
• Westermark P, Westermark GT, Suhr OB, et al. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups J Med Sci. 2014;119(3):223–228.
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Ueda M, Jono H, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol. 2011;42(9):1259–1264.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217–222.
   PubMed Web of Science ®Google Scholar
• Yanagisawa A, Ueda M, Sueyoshi T, et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol. 2015;28(2):201–207.
   PubMed Web of Science ®Google Scholar
• Tasaki M, Milani P, Foli A, et al. Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients. Blood. 2019;134(3):320–323.
   PubMed Web of Science ®Google Scholar
• Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114(24):4957–4959.
   PubMed Web of Science ®Google Scholar
• Tasaki M, Ueda M, Hoshii Y, et al. A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1. J Pathol. 2019;247(4):444–455.
   PubMed Web of Science ®Google Scholar
• Paoletti AC, Parmely TJ, Tomomori-Sato C, et al. Quantitative proteomic analysis of distinct mammalian mediator complexes using normalized spectral abundance factors. Proc Natl Acad Sci U S A. 2006;103(50):18928–18933.
   PubMed Web of Science ®Google Scholar
• Nichols WC, Dwulet FE, Liepnieks J, et al. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun. 1988;156(2):762–768.
   PubMed Web of Science ®Google Scholar
• Obici L, Bellotti V, Mangione P, et al. The new apolipoprotein A-I variant Leu174 → Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol. 1999;155(3):695–702.
   PubMed Web of Science ®Google Scholar
• Rowczenio D, Dogan A, Theis JD, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol. 2011;179(4):1978–1987.
   PubMed Web of Science ®Google Scholar
• Hamidi Asl L, Liepnieks JJ, Hamidi Asl K, et al. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol. 1999;154(1):221–227.
   PubMed Web of Science ®Google Scholar
• Mucchiano GI, Häggqvist B, Sletten K, et al. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol. 2001;193(2):270–275.
   PubMed Web of Science ®Google Scholar
• Westermark P, Mucchiano G, Marthin T, et al. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol. 1995;147(5):1186–1192.
   PubMed Web of Science ®Google Scholar
• Solomon A, Murphy CL, Kestler D, et al. Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. Arthritis Rheum. 2006;54(11):3545–3550.
   PubMedGoogle Scholar
• Yanagisawa A, Ueda M, Sueyoshi T, et al. Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid. Amyloid. 2016;23(1):26–32.
   PubMed Web of Science ®Google Scholar
• Ono K, Takahashi R, Ikeda T, et al. Cross-seeding effects of amyloid β-protein and α-synuclein. J Neurochem. 2012;122(5):883–890.
   PubMed Web of Science ®Google Scholar
• Vasconcelos B, Stancu IC, Buist A, et al. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo. Acta Neuropathol. 2016;131(4):549–569.
   PubMed Web of Science ®Google Scholar
• Guo JL, Covell DJ, Daniels JP, et al. Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell. 2013;154(1):103–117.
   PubMed Web of Science ®Google Scholar
• Morales R, Moreno-Gonzalez I, Soto C. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog. 2013;9(9):e1003537.
   PubMed Web of Science ®Google Scholar
• Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332–1340.
   PubMed Web of Science ®Google Scholar
• Misumi Y, Ando Y, Ueda M, et al. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy. J Pathol. 2009;219(4):481–490.
   PubMed Web of Science ®Google Scholar